HopeStage
Back to all studies
CompletedNCT00446992

Blood sugar and weight changes after starting antipsychotic treatment

About this titleRead the official source — NCT00446992
Medication studyAges 18–64SpainSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 64 years.

What did participation involve?

The study group receives olanzapine as a study medication.

Listed locations
BarcelonaSee all locations and recruitment
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateApril 2006
Recruitment status
Completed
Enrollment listed in the registry
30
Sponsor
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Sponsor type
Research institute
Study type
Drug
Intervention type
Drug
Study phase
Phase 1 / Phase 2This study spans more than one phase, so it may combine goals such as safety, dosing, and early effectiveness.
Locations
Spain
Age range
From 18 Years to 64 Years
Official registry ID
NCT00446992
Official title
Show the full official title

Metabolic Effects of Olanzapine in Patients With Newly Diagnosed Psychosis

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Barcelona

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), a research institute.

Did this study involve medication?

Yes. The study involved medication, including Olanzapine.

Who was this study for?

Listed age limits: 18 years to 64 years.

Want to explore more studies?

Explore studies